Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Predicting outcome of IgA nephropathy by use of urinary epidermal growth factor: monocyte chemotactic peptide 1 ratio

Nature Clinical Practice Nephrology volume 4, pages 184–185 (2008)Cite this article

boxed-textTorres DD et al. (2008) The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. Kidney Int 73: 327–333

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Fliser D et al. (2007) Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol 18: 1057–1071

    Article  CAS  Google Scholar 

  2. Bonventre J (2007) Diagnosis of acute kidney injury: from classic parameters to new biomarkers. In Acute Kidney Injury, 213–219 (Eds Ronco C et al.) Basel: Karger

    Chapter  Google Scholar 

  3. Gesualdo L et al. (1996) Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunohistochemical and in situ hybridization study. Kidney Int 49: 656–665

    Article  CAS  Google Scholar 

  4. Wada T et al. (2000) Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 58: 1492–1499

    Article  CAS  Google Scholar 

  5. Eardley KS et al. (2006) The relationship between albuminuria, MCP1/CCL2, and interstitial macrophages in chronic kidney disease. Kidney Int 69: 1189–1197

    Article  CAS  Google Scholar 

  6. Ding H et al. (2007) Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol 123: 227–234

    Article  CAS  Google Scholar 

  7. Vaidya VS et al. (2008) Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol 48: 463–493

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Department of Laboratory Medicine, Graduate School of Medical Science, Kanazawa University, 13–1 Takara-machi, Kanazawa 920–8641, Japan twada@m-kanazawa.jp

Authors and Affiliations

  1. T Wada is a Professor in the Department of Laboratory Medicine and Director of the Division of Nephrology at Kanazawa University, Kanazawa, Japan.,

    Takashi Wada

Authors
  1. Takashi Wada
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wada, T. Predicting outcome of IgA nephropathy by use of urinary epidermal growth factor: monocyte chemotactic peptide 1 ratio. Nat Rev Nephrol 4, 184–185 (2008). https://doi.org/10.1038/ncpneph0760

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0760

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing